United Kingdom · Question · Written question
UIN 201608
Voluntary Scheme for Branded Medicines Pricing and Access
Original
Introduced
13 October 2023
Last action
20 October 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 October 2023
Summary
To ask the Secretary of State for Health and Social Care, with reference to the proposed update to the 2023 statutory scheme to control the cost of branded health services medicines, what (a) evidential basis and (b) analysis his Department considered whe
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 October 2023
Written question
To ask the Secretary of State for Health and Social Care, with reference to the proposed update to the 2023 statutory scheme to control the cost of branded health services medicines, what (a) evidential basis and (b) analysis his Department considered whe
Source: Commons
20 October 2023
Answer
The Government is currently consulting on updates to the statutory scheme to make sure that the scheme can continue to meet its objectives from 2024 onwards. The evidential basis and analysis considered is set out in the consultation stage impact assessme...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-10-13/201608
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1663755
- uk · wq-1663755 · source updated 20 October 2023